X You are viewing the latest eNews for Pharmacists, our weekly email newsletter sent to thousands of professionals and students.

[Return Home]
[Subscribe for Free]
[Become a Sponsor]



NEWS-Line - eNews

FEATURED SPONSOR:

Alliance For Clinical Trials In Oncology
Manager, Pharmaceutical Affairs

Chicago Illinois

Job Board
Find a Job Near You

Nationwide


SPONSORS:

Sign In / Sign Up

Jobs RSS Feed

Your Weekly eNews from NEWS-Line.

Please "Like" NEWS-Line on Facebook and follow us on Twitter, Pinterest, and Linkedin.  Bookmark www.news-line.com to read all of the latest healthcare news that is posted daily.

Also, the January issue of NEWS-Line is available to read on your computer or electronic device. And remember . . . you can take NEWS-Line everywhere with you! Just save www.NEWS-Line.com to your phone for the latest news, jobs, education and blogs!

 



NEWS:

How Treating Eczema Could Also Alleviate Asthma

Scientists from VIB-UGent have discovered insights for a possible new therapy for eczema that also reduces the severity of asthma. The findings are an important next step in understanding the relationship between the two inflammatory diseases and to developing effective therapies. The results of the study are published in the Journal of Investigative Dermatology.

Children with atopic dermatitis (AD), a type of eczema of the skin, show an increased risk of developing asthma later in life. This phenomenon, also known as atopic march, raises questions on whether therapies can be developed that not only tackle AD, but also prevent the onset of other allergic diseases. Intrigued by this possibility, a team of VIB scientists took to the lab.

Marching from the skin to the lungs

House dust mites are known culprits in the development of both AD and asthma, as exposure to the mites induces infl

Read Full Article



Default Setting In Electronic Medical Records “Nudged” Emergency Department Physicians To Limit Opioid Prescriptions To 10 Tablets

For patients who have never been prescribed opioids, larger numbers of tablets given with the initial prescription is associated with long-term use and more tablets leftover that could be diverted for misuse or abuse. Patients may receive 30 or more opioid tablets in an initial prescription, for example, when a much lesser quantity, such as 10-12 tablets as recommended by current emergency department prescribing guidelines, would suffice. Implementing a default option for a lower quantity of tablets in the electronic medical records (EMR) discharge orders may help combat the issue by “nudging” physicians to prescribe smaller quantities consistent with prescribing guidelines Penn Medicine researchers show in a new study published this week in the Journal of General Internal Medicine.

The research team found that physicians from two Penn Medicine emergency departments prescribed a fewer n

Read Full Article

Having A Pharmacist At Stroke Patient's Bedside Speeds Administration Of Critical Drug

It's sometimes possible to stop a stroke in its tracks by giving the patient a clot-busting drug called rtPA, which restores blood flow in the brain.

The faster rtPA is given, the better the outcome. Now a Loyola Medicine study has found that having a pharmacist at the patient's bedside can reduce the time it takes to administer rtPA by a median of 23.5 minutes.

The study by pharmacists Megan A. Rech, PharmD, Stephanie Bennett, PharmD, and Elisabeth Donahey, PharmD, is published in the journal Annals of Pharmacotherapy.

Each year, about 800,000 people in the United States have a stroke – about one person every 40 seconds. Stroke is the fifth leading cause of death in the United States.

Most strokes are ischemic, meaning they are caused by blood clots that block blood flow to areas of the brain. Every minute a stroke goes untreated, about 1.9 million brain cells die.

If given qu

Read Full Article

Asthma Costs The US Economy More Than $80 Billion Per Year

Asthma costs the US economy more than $80 billion annually in medical expenses, missed work and school days and deaths, according to new research published online in the Annals of the American Thoracic Society.

In “The Economic Burden of Asthma in the United States, 2008-2013,” researchers from the Centers for Disease Control and Prevention analyzed data from the Medical Expenditure Panel Survey, the most comprehensive source of data on health care use, expenditures, payment source and health insurance coverage in the US.

“The cost of asthma is one of the most important measures of the burden of the disease,” said Tursynbek Nurmagambetov, PhD, lead study author and health economist at the Centers for Disease Control and Prevention. “Cost studies can influence health policy decisions and help decision makers understand the scale, seriousness and implications of asthma, so that resource

Read Full Article

More News


LINKS:




UPCOMING EVENTS:

Summer Meetings and Exhibition

06/02/2018 - 06/06/2018
American Society of Health-System Pharmacists

2018 Midyear Clinical Meeting

12/02/2018 - 12/06/2018
American Society of Health-System Pharmacists


Would you like to be Featured
in NEWS-Line for
Pharmacists?

Click Here